MDxHealth (MDXH) Scheduled to Post Quarterly Earnings on Wednesday

MDxHealth (NASDAQ:MDXH) will be announcing its earnings results after the market closes on Wednesday, August 21st. Analysts expect the company to announce earnings of ($0.26) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

MDxHealth Trading Up 7.3 %

Shares of NASDAQ MDXH opened at $3.39 on Tuesday. MDxHealth has a fifty-two week low of $2.15 and a fifty-two week high of $4.64. The company has a debt-to-equity ratio of 5.43, a quick ratio of 1.53 and a current ratio of 1.69. The business has a 50-day moving average of $2.67 and a 200-day moving average of $2.85.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.